Cost-of-Living Win: Government Scraps Repeat Prescription Fees in Major U-Turn
By Lions Roar News Political Desk
WELLINGTON, NEW ZEALAND (January 10, 2026) — In a significant policy reversal, the Government has announced that New Zealanders will only pay a single $5 co-payment fee for the new 12-month prescriptions set to launch next month.
The move marks a backtrack from initial plans that would have seen patients charged $5 every three months when collecting their medication repeats. The change is aimed at easing the financial burden on the nearly 200,000 Kiwis who currently skip collecting their medicine due to costs.
💊 How the New System Works
Starting February 1, 2026, the maximum prescription length for many long-term conditions will extend from three months to a full year.
- The Single Fee: Patients will pay $5 at the first collection. The remaining three collections (needed every three months) will now be free of charge.
- Potential Savings: This change will save regular prescription users up to $15 per year per medication.
- Targeted Conditions: The extended prescriptions are specifically designed to help those managing chronic conditions such as asthma, diabetes, epilepsy, and high blood pressure.
📉 The Decision to “Rescind”
Documents proactively released by the Ministry of Health show that the initial decision to charge every three months was made to “mitigate the financial impact” on Health New Zealand. However, Health Minister Simeon Brown recommended the u-turn, arguing that the repeat fees directly contradicted the policy’s goal of reducing costs for patients.
“The previous decision does not align with the policy intent to reduce costs to patients,” Minister Brown stated in the Cabinet papers. “To achieve this policy intent, the additional co-payment every three months needs to be removed.”
The removal of these fees is expected to cost Health New Zealand between $6 million and $23 million annually, a figure expected to grow by 5% each year.
🏥 Sector Reaction: “A Great Thing”
The Pharmacy Guild has welcomed the move, noting it removes barriers to healthcare.
- Affordability: Chief Executive Andrew Gaudin praised the decision for making medicine and GP visits more accessible.
- Pharmacist Support: The government has also agreed to “fully mitigate” planned fee cuts to pharmacists, ensuring community pharmacies are not financially penalized for the longer prescription cycles.
- Prescribing Power: From February 1, more pharmacists will also be legally allowed to act as prescribers, though the sector warns it may take time for many to be fully ready for the change.
